Showing results (191-200 of 420) with videos related to
Sort By:
Pageof 42
The Journal of Experimental Medicine|October 30, 2009
RELATION OF A beta(1)-GLYCOPROTEIN OF HUMAN SERUM TO THE COMPLEMENT SYSTEMH J Müller-Eberhard, U NilssonJournal of Immunology (Baltimore, Md. : 1950)|March 1, 1980
The ninth component of human complement: purification and physicochemical characterizationG Biesecker, H J Müller-EberhardMolecular Immunology|March 1, 1983
The C3/C5 convertase of the alternative pathway of complement: stabilization and restriction of control by lanthanide ionsZ Fishelson, H J Müller-EberhardJournal of Immunology (Baltimore, Md. : 1950)|March 1, 1984
Residual hemolytic and proteolytic activity expressed by Bb after decay-dissociation of C3b,BbZ Fishelson, H J Müller-EberhardEuropean Biophysics Journal : EBJ|January 1, 1987
Chain length and pressure dependence of lipid translational diffusionH J Müller, H J GallaThe Quarterly Journal of Experimental Psychology. A, Human Experimental Psychology|November 1, 1989
Spatial cueing and the relation between the accuracy of "where" and "what" decisions in visual searchH J Müller, P M RabbittClinical Pharmacology and Therapeutics|December 9, 1997
Dexamethasone down-regulates the expression of L-selectin on the surface of neutrophils and lymphocytes in humansB Jilma, J Voltmann, S Albinni, et al.International Journal of Clinical Pharmacology and Therapeutics|October 26, 2005
What do primary care patients think about generic drugs?W Himmel, A Simmenroth-Nayda, W Niebling, et al.Toxicology and Applied Pharmacology|September 1, 2009
Toxicogenomic analysis of N-nitrosomorpholine induced changes in rat liver: comparison of genomic and proteomic responses and anchoring to histopathological parametersA Oberemm, H-J Ahr, P Bannasch, et al.Journal of Clinical Pharmacology|November 10, 1998
When are bioavailability studies required? A German proposalC H Gleiter, U Klotz, J Kuhlmann, et al.Pageof 42